In a double-blind, placebo-controlled, randomized study, we have investigated the efficacy of i.m. ephedrine in 98 elderly patients undergoing hip arthroplasty under spinal anaesthesia with plain bupivacaine. Fifty patients received ephedrine 0.6 mg kg" 1 body weight, deep in the paravertebral muscles immediately after injection of bupivacaine, and 48 received an equal volume of saline. Patients in both groups were given the same volumes of fluid before anaesthesia. Systolic arterial pressure during the first 60 min after anaesthesia remained significantly more stable in the ephedrine-treated group, and there was also a significantly smaller number of patients in this group who had decreases in pressure of more than 30% of pre-block levels, and fewer required rescue i.v. ephedrine. An increase in heart rate or systolic pressure of ^ 20% from baseline was found in two patients in the ephedrine group and in one patient in the placebo group. We conclude that ephedrine 0.6 mg kg" 1 body weight administered in the paravertebral muscles immediately after plain bupivacaine spinal anaesthesia is a simple and effective means of reducing the incidence of hypotensive episodes in the elderly patient. (Br. J. Anaesth. 1995; 74: 517-520) 
In a double-blind, placebo-controlled, randomized study, we have investigated the efficacy of i.m. ephedrine in 98 elderly patients undergoing hip arthroplasty under spinal anaesthesia with plain bupivacaine. Fifty patients received ephedrine 0.6 mg kg" 1 body weight, deep in the paravertebral muscles immediately after injection of bupivacaine, and 48 received an equal volume of saline. Patients in both groups were given the same volumes of fluid before anaesthesia. Systolic arterial pressure during the first 60 min after anaesthesia remained significantly more stable in the ephedrine-treated group, and there was also a significantly smaller number of patients in this group who had decreases in pressure of more than 30% of pre-block levels, and fewer required rescue i.v. ephedrine. An increase in heart rate or systolic pressure of ^ 20% from baseline was found in two patients in the ephedrine group and in one patient in the placebo group. We conclude that ephedrine 0.6 mg kg" Ephedrine is an alkaloid originally extracted from the Chinese plant Ma Huang, used in traditional Chinese medicine for centuries. In the late 1920s, this sympathomimetic amine was introduced as a vasopressor into anaesthetic practice by Ockerblad and Dillon [1] . Its modern synthetic congener remains a drug of choice for treating hypotension induced by spinal or extradural anaesthesia [2] . The dose and timing of administration, however, have not been fully investigated, although the trend today seems to favour i.v. administration, either in titrated single doses or as a continuous infusion. The efficacy of prophylactic i.m. ephedrine has been questioned and there is concern regarding the potential for causing harmful hypertension or tachycardia [2] [3] [4] [5] . However, Hemmingsen, Poulsen and Risbo administered a combination of i.v. and i.m. ephedrine after bupivacaine spinal anaesthesia, and found this regimen satisfactory in counteracting hypotension without undue hypertension or tachycardia [6] . In all previous studies with the i.m. route, fixed doses of ephedrine have been used.
The aim of our study was to investigate the efficacy of ephedrine in maintaining haemodynamic stability in elderly patients when administered in a single i.m. dose determined by body weight and given at the same time as spinal anaesthesia.
Patients and methods
This double-blind, placebo-controlled, randomized study was approved by the Ethics Committee at the University in Linkoping. We studied 100 consecutive patients undergoing total hip replacement under spinal anaesthesia with plain bupivacaine. One patient was excluded as it was not possible to perform the spinal block, and another because of incomplete data, leaving 98 patients for evaluation. Premedication was given approximately 1 h before anaesthesia with i.m. ketobemidone 5-10 mg and i.m. dixyrazine 10-20 mg according to age and body weight (ketobemidone is not available in the UK; ketobemidone is an opioid, 5 mg is equipotent to morphine 5-8 mg [7] , dixyrazine is a low-dose phenothiazine with sedative and marked antiemetic properties [8] ). Patients medicated with beta receptor or calcium channel blockers were given their ordinary morning doses. During the 20-min period before anaesthesia the patients received 3 % dextran solution (Plasmodex, Pharmacia AB, Sweden) 7 ml kg" 1 body weight. Systolic arterial pressure (SAP) was measured with a calibrated aneroid sphygmomanometer and radial pulse palpation. Heart rate (HR) was obtained from a three-lead ECG. Spinal anaesthesia with 0.5 % plain bupivacaine 20 mg was performed in the L2-3 or L3-4 interspaces with the patient in the sitting position. Morphine 0.3 mg was added to the bupivacaine solution. Immediately after completion of the spinal injection, the needle was withdrawn and redirected laterally, and 0.012 ml kg" 1 body weight of the trial solution was injected deep into the paravertebral muscles. The solution comprised either ephedrine 0.6 mg kg" the 3 % dextran solution was continued at a rate of 1 ml kg" 1 h" 1 and a crystalloid solution with 2.5 % glucose (Rehydrex Pharmacia AB, Sweden) was started and continued at a rate of 4 ml kg" 1 h" 1 throughout surgery. A decrease in SAP of > 30 % from the baseline recording to less than 100 mm Hg was treated immediately with i.v. ephedrine in 5-mg increments until a stable SAP above this threshold level was established. Plasma volume maintenance with 3% dextran (in addition to the continuous infusion rate of 1 ml kg" 1 h"
1
) and packed red cell transfusions to compensate for intraoperative blood loss were based on a computer-generated scheme for each individual patient, taking into account age, sex, body weight and height, preoperative haemoglobin (Hb) concentration and predetermined lowest acceptable postoperative Hb. In order to provide a comfortable state during surgery, midazolam was administered as required in doses of 1.25 mg. In a few patients small doses of i.v. fentanyl were given to alleviate pain from unanaesthetized areas caused by the uncomfortable lateral position. Dixyrazine was given in i.v. doses of 5 mg to treat nausea.
SAP and HR were recorded before anaesthesia, 2 and 5 min after anaesthesia, and every 5 min thereafter. All SAP measurements were obtained from the upper arm. A reduction in SAP > 30 % from the baseline level was considered a negative outcome in terms of efficacy, whereas increases in SAP ^ 20 % to a level ^160 mm Hg, and in HR ^ 20 % to a level 90 beat min" 1 were considered adverse reactions. The groups were compared by Mann-Whitney U test and regression analysis, as appropriate. P < 0.05 was considered significant.
Results
There were no differences between the groups in patient characteristics, baseline haemodynamic state, time from anaesthesia to surgery, intraoperative volume replacement or bleeding (table 1). There were no significant differences in the amount of midazolam or fentanyl given within 5, 10, 30 and 60 min after anaesthesia or in the total cumulated doses throughout the whole procedure (table 2) . Spinal anaesthesia was successful in all patients. The median values of the upper segmental sensory level of the spinal anaesthesia (determined by the cold discrimination test) were T4 (range T3-10) and T5 (T2-10) for the ephedrine-treated and placebo groups, respectively. Regression analysis did not reveal any significant relation between the level of sensory analgesia and SAP every 5 min during the first 60 min after the block. The incidence of nausea and vomiting and the amounts of antiemetics administered during operation and within 12 h after operation did not differ significantly between the groups. SAP in the placebo group was significantly lower compared with the ephedrine group when assessed every 5 min after anaesthesia, and the reduction in SAP compared with the corresponding baseline value was significantly more pronounced in the placebo group 10 min after anaesthesia (P < 0.008) and throughout the first hour after anaesthesia ( fig. 1 ). There were also statistically significant differences between the groups in the percentage of patients given rescue i.v. ephedrine aimed at maintaining SAP above the threshold level ( fig. 2 ). These differences were apparent when the groups were compared during the first 60 min after anaesthesia, and also throughout the whole procedure.
The number of patients with reductions in SAP of more than 30% from the baseline level was significantly lower in the ephedrine group at 10, 25, 45, 50 and 55 min after anaesthesia (table 3) . No patient in the placebo group received midazolam or fentanyl within 10 min after anaesthesia and after sedatives or analgesics were administered, no correlations between SAP and administration of these drugs were found. Seven patients in the ephedrine group and 12 in the placebo group were receiving medication with beta adrenergic, calcium channel blockers, or both. In these patients the value of SAP was higher at all times after anaesthesia if prophylactic ephedrine had been given and this difference was statistically significant at 10 min, and between 35 and 60 min of anaesthesia. The need for rescue i.v. ephedrine in patients treated with beta adrenergic, calcium channel blockers, or both, was significantly less if prophylactic ephedrine had been given (table 4). In the corresponding subgroup of patients not treated with beta adrenergic or calcium channel blockers, the significant differences in SAP between the two groups were consistent with the data for all of the patients studied, as indicated in figure 1 . The need for rescue ephedrine in patients not treated with beta adrenergic or calcium channel blockers is shown in table 4.
An increase of more than 20% in SAP (from 160 to 210mmHg) was observed in one patient in the ephedrine-treated group. HR was unchanged at 120 beat min" 1 . One patient in each group had an increase in HR of more than 20%, the one in the untreated group from 95 to 125 beat min" 1 and in the ephedrine group from 80 to 107 beat min" 1 .
Discussion
Hypotension after spinal or extradural block may be hazardous in patients with a compromised arterial supply to vital organs (i.e. coronary and cerebral circulations), but may also reflect a reduction in afterload, which in most cases is beneficial [3] . As there is no method to assess with accuracy the lowest acceptable arterial pressure in the individual patient, the decision to administer drugs to increase arterial pressure is dependent on the anaesthetist's judgement. Thus our decision to give i.v. ephedrine if SAP decreased by more than 30% to less than 100 mm Hg was partly empirical.
It has been observed that volume expansion alone with colloid or crystalloid solutions has not been consistently effective in attenuating hypotension induced by spinal or extradural anaesthesia and it may even by harmful in the elderly patient with incipient heart failure [2, 3] . Of the vasoactive drugs suitable for prophylaxis, ephedrine is generally agreed as the most appropriate. I.v. infusions of ephedrine or intermittent i.v. doses titrated to response are the techniques most often recommended. However, as hypotension may develop rapidly after spinal anaesthesia, optimal SAP control with these techniques calls for very close monitoring by invasive or automated techniques, and these are not always feasible. On the other hand, i.m. prophylactic administration of ephedrine is generally not recommended because of the alleged unpredictable absorption from the injection site and the belief that a relative overdose may result in hypertension, Table 4 Number of administered rescue doses of ephedrine (5 mg tachycardia, or both, which may be detrimental [2, 3] . Indeed, use of the i.m. route in obstetric spinal or extradural anaesthesia has been condemned. In a study by Rolbin and colleagues in which ephedrine was given i.m. 15-30 min before extradural anaesthesia for elective Caesarean section, ephedrine 25 mg was ineffective in reducing the incidence of maternal hypotension, while a dose of 50 mg produced unacceptable hypertension which was associated with derangement in fetal acid-base status [4] . Rout and co-workers also recommended that prophylactic i.m. ephedrine not be used before obstetric spinal or extradural anaesthesia in case the block should fail and it became necessary to resort to general anaesthesia [5] . However, in non-obstetric cases, Hemmingsen, Poulsen and Risbo administered i.m. ephedrine 37.5 mg after an initial i.v. bolus of 12.5 mg. This was compared with placebo in 48 patients undergoing surgery of the lower abdomen or lower extremities during bupivacaine spinal anaesthesia. Greater stability of arterial pressure occurred in ephedrine-treated patients, especially in a subgroup of ASA III patients, where all eight patients in the placebo group had a decrease in mean arterial pressure exceeding 33 % compared with none in the ephedrine-treated group. Tachycardia or hypertension was not observed [6] .
It seems that the problem associated with i.m. ephedrine is that of a reliable regimen which is both effective and also avoids overdosage. Surprisingly, matching the dose to body mass has not been undertaken in the earlier studies. From our previous clinical experience it seemed that an i.m. dose of 0.6 mg kg" 1 was appropriate and that reliable absorption could be expected if ephedrine was injected deep into the paravertebral muscles. In our study we found that this regimen provided a significant stabilizing effect on SAP throughout the study period of 1 h and that this effect was evident both in the presence and absence of beta adrenergic or calcium channel blockers, or both.
The detailed part of this study was terminated 60 min after anaesthesia, as we expected that the effects of i.m. ephedrine would have terminated within this period and also we expected that any difference in haemodynamic state would be influenced or obscured by surgical blood loss and cementing. Nevertheless, the percentage of patients treated with i.v. ephedrine after the first 60 min was also significantly higher (70 % vs 31 %; P < 0.001) in the placebo group.
The price paid for SAP stability in the ephedrine group may have been a 31 % increase in SAP in a patient suffering from heart failure, atrial fibrillation and diabetes who was haemodynamically unstable both before and during anaesthesia. Increases in HR occurred in one patient in each group. These results must be weighed against the significantly inferior haemodynamic stability in a substantial number of patients in the placebo group. The incidence of nausea and vomiting during and after operation was not affected by the use of ephedrine [9] and there was no effect on blood loss and need for intraoperative transfusion [10] . Finally, it should be emphasized that we used plain bupivacaine, which has a rather slow onset of action compared with other local anaesthetics [11] . Our results can not be indiscriminately applied therefore to all situations where spinal anaesthesia is used.
